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Usefulness of the second heart sound for predicting pulmonary 
hypertension in patients with interstitial lung disease
Utilidade da segunda bulha cardíaca na predição de hipertensão pulmonar em 
portadores de doenças intersticiais pulmonares
Sandra de Barros CobraI, Rayane Marques CardosoII, Marcelo Palmeira RodriguesIII
Universidade de Brasília (UnB), Brasília, Distrito Federal, Brazil
ABSTRACT
CONTEXT AND OBJECTIVE: P2 hyperphonesis is considered to be a valuable finding in semiological di-
agnoses of pulmonary hypertension (PH). The aim here was to evaluate the accuracy of the pulmonary 
component of second heart sounds for predicting PH in patients with interstitial lung disease.
DESIGN AND SETTING: Cross-sectional study at the University of Brasilia and Hospital de Base do Distrito Federal.
METHODS: Heart sounds were acquired using an electronic stethoscope and were analyzed using phono-
cardiography. Clinical signs suggestive of PH, such as second heart sound (S2) in pulmonary area louder than 
in aortic area; P2
 > A2 in pulmonary area and P2 present in mitral area, were compared with Doppler echocar-
diographic parameters suggestive of PH. Sensitivity (S), specificity (Sp) and positive (LR+) and negative (LR-) 
likelihood ratios were evaluated. 
RESULTS: There was no significant correlation between S2 or P2 amplitude and PASP (pulmonary artery 
systolic pressure) (P = 0.185 and 0.115; P= 0.13 and 0.34, respectively). Higher S2 in pulmonary area than 
in aortic area, compared with all the criteria suggestive of PH, showed S  =  60%, Sp= 22%; LR+  =  0.7; 
LR- = 1.7; while P2> A2 showed S= 57%, Sp = 39%; LR+ = 0.9; LR- = 1.1; and P2 in mitral area showed: S= 
68%, Sp = 41%; LR+ = 1.1; LR- = 0.7. All these signals together showed: S= 50%, Sp = 56%.
CONCLUSIONS: The semiological signs indicative of PH presented low sensitivity and specificity levels for 
clinically diagnosing this comorbidity.
RESUMO
CONTEXTO E OBJETIVO: Hiperfonese de P2 tem sido considerada como achado valoroso no diagnóstico 
semiológico de hipertensão pulmonar (HP). O objetivo foi de avaliar a acurácia do componente pulmonar 
da segunda bulha cardíaca em predizer HP nos pacientes portadores de doenças intersticiais pulmonares.
TIPO DE ESTUDO E LOCAL: Estudo transversal na Universidade de Brasília e Hospital de Base do 
Distrito Federal.
MÉTODOS: Os sons cardíacos foram adquiridos com estetoscópio eletrônico e analisados por fono-
cardiografia. Os sinais clínicos sugestivos de HP, como B2 mais intensamente audível em área pulmonar 
que aórtica, P2 > A2 na área pulmonar e P2 presente em área mitral foram confrontados com parâmetros 
cardiográficos no exame de Doppler sugestivos de HP. Sensibilidade (S), especificidade (E), razões de 
verossimilhança positiva (RV+) e negativa (RV-) foram avaliados.
RESULTADOS: Não houve correlação significativa entre amplitude de B2 e P2 e a PSAP (pressão sistólica 
arterial pulmonar) (P = 0,185 e 0,115; P = 0,13 e 0,34; respectivamente). A análise da presença de B2 
mais intensa na área pulmonar que aórtica, quando comparada a todos os critérios sugestivos de HP, 
mostrou S = 60%; E = 22%; RV+ = 0,7; RV- = 1,7; enquanto P2 > A2 mostrou: S = 57%; E = 39%; RV+ = 0,9; 
RV- = 1,1; e P2 no foco mitral mostrou: S = 68%; E = 41%; RV+ = 1,1; RV- = 0,7. Todos os sinais juntos 
mostraram S = 50%; E = 56%.
CONCLUSÃO: Os sinais semiológicos indicativos de HP apresentam baixos valores de especificidade e 
sensibilidade para diagnóstico clínico dessa comorbidade.
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INTRODUCTION
Interstitial lung diseases are a heterogeneous group of disor-
ders that affect the lung parenchyma. However, despite their 
differences, they all share chronic evolution associated with 
functional and structural deterioration of the pulmonary paren-
chyma.1 This process is often also accompanied by pulmonary 
hypertension (PH), caused either by hypoxic pulmonary vaso-
constriction or direct vascular impairment of vascular function, 
such as occurs in sarcoidosis.2 The presence of PH is a predic-
tor of mortality.3
Detecting the presence of PH is important because this dis-
order is a determining factor for various therapeutic measures, 
among them lung transplantation.3 Moreover, a finding of PH 
may signal inapparent hypoxemia, such as occurs repeatedly 
during sleep or upon physical effort. Therefore, prompt and easy 
identification of factors that can provide additional informa-
tion about the evolution of the disease is extremely important. 
In 1970, Harris4 considered that both the intensity of the sec-
ond heart sound (S2) and its behavior during breathing deserved 
attention during routine auscultation. A change in its character-
istics could be an early clinical sign of PH.5
In this scenario, splitting of S2 mainly occurs because of 
delays in the pulmonary component (P2), although there is 
a slight advance of the aortic component (A2). This occurs 
even during expiration, with a delay of 0.02 to 0.03 seconds, 
and  0.02 in only 2% of the population, especially in chil-
dren and young adults.6
Hyperphonesis of P2 has traditionally been acknowledged 
in all semiology books as indicative of PH. However, there is 
little evidence to support this. It is defined as more accentu-
ated presence of S2 in the pulmonic area than in the aortic area5 
or, more specifically, as P2 > A2 in the pulmonic area. It shows 
highly variable sensitivity (S) (96% to 58%) and specificity (Sp) 
(46% to 19%).5,7
In fact, it is not uncommon for a semiological tradition to 
be established based on pathophysiological deductions, with-
out proper clinical validation of the finding, including its per-
ceived variability, which has a direct relationship with the cred-
ibility and routine application of this knowledge on a daily basis. 
For instance, the reliability of cardiac auscultation findings is 
rarely evaluated. Regardless of these issues, hyperphonesis of P2 
is still included in the guidelines for PH as an indicator of this 
condition.8
If, on the one hand, the benefits arising from a useful clini-
cal finding, as a means for diagnosis that is doubly accessible in 
terms of both cost and speed of recognition, are enormous; on the 
other hand, acceptance of unproven validity can be harmful to 
the same extent. Therefore, it is increasingly important to deter-
mine the accuracy and real reliability of these clinical findings. 
OBJECTIVE
In this study, we aimed to evaluate the pulmonary component of 
S2 as a predictor of PH in patients with interstitial lung diseases. 
We also attempt to determine the pulmonary artery systolic pres-
sure (PASP) value at which the pulmonary component of S2 
would be a more useful predictor of PH.
METHODS
This was a cross-sectional study from March to November 2011, 
in which 69 patients with various interstitial lung diseases seen in 
the outpatient care of a tertiary-level hospital were consecu-
tively examined. This number was defined a priori, assuming an 
effect size of 0.4 w for the outcome, which represents a moder-
ate to great effect, in addition to 80% power and an α value of 
5%.9 The study protocol was approved by our institution’s ethics 
committee and all the participating subjects signed an informed 
consent form.
Each participating patient underwent cardiac auscultation 
in a quiet environment, in the supine position, with spontane-
ous breathing. The sounds were recorded using a 3MM Littmann 
electronic stethoscope, model 3200 (St. Paul, MN, USA) for fur-
ther analysis. Next, the patient underwent color Doppler echo-
cardiography carried out by a single examiner who was unaware 
of any of the clinical data. Electrocardiographic monitoring was 
done during the test. 
We evaluated 69 patients aged between 21 and 86 years, with 
a mean age of 58 ± 16.6 years. Twenty-eight subjects (40.6%) 
were male and 41 (59.4%), female. Regarding the distribution 
of diseases, 15 patients (21.7%) had idiopathic pulmonary fibro-
sis, 22 (32%) had idiopathic interstitial diseases, 11 (16%) had 
interstitial lung disease associated with collagen-vascular disease, 
nine (13%) had sarcoidosis, seven (10.1%) had chronic hypersen-
sitivity pneumonia and five (7.2%) presented other diffuse inter-
stitial lung diseases.
Phonocardiogram
Phonocardiograms corresponding to heart sounds obtained by 
means of an electronic stethoscope were recorded in the aortic, 
pulmonic, mitral and tricuspid areas. The recording was done 
during spontaneous and continuous breathing.
The pulse tracings were transformed into signals by means of 
the Zargis Cardioscan heart sound analysis software (Princeton, 
NJ, USA) and were adjusted for reading in accordance with the 
same measurement scale. The amplitude of S2 was measured 
(with or without splitting) and the amplitude of its P2 component 
was measured separately; both measurements were obtained in 
the pulmonic area.
The parameters subsequently evaluated were the relative 
intensities of A2 and P2 in the pulmonic area; occurrences of 
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P2 of greater amplitude than A2 (P2 > A2); P2 in the mitral area; 
absence of splitting of S2; and, finally, simultaneous occurrence 
of all the parameters.
The analyses were performed by three independent exam-
iners. They took into consideration the sounds, the pulse trac-
ings and the additional features of the software, which made it 
possible to view the spectrums of the phonographic wave forms, 
among other things. Decisions were then based on the consensus 
reached among the examiners.
Phonocardiogram results were also compared with PASP mea-
surements by means of Doppler echocardiography, using Doppler 
and additional criteria for diagnosing PH, as described below.
Transthoracic Doppler echocardiography
For transthoracic Doppler echocardiography evaluations, the 
patients were examined in the left lateral decubitus position, 
using standard echocardiographic projections. We used an ultra-
sound machine (model Vivid S5, General Electric. Milwaukee, 
WI, USA) with a multifrequency transducer and a frequency 
range from 2.5 to 3.5 MHz.
Measurements of variables relating to the heart chambers 
and ventricular function were obtained as established by the 
American Society of Echocardiography.10
Doppler analyses were performed in real time. Doppler color 
flow mapping in multiple views was used in order to more accu-
rately measure tricuspid regurgitation. We used continuous wave 
Doppler ultrasound at a sweep speed of 50-100 mm/sec. Three to 
five measurements per pulse tracing were taken. 
To calculate PASP by measuring tricuspid regurgitation, we 
used the modified Bernoulli equation. We then obtained the 
pressure gradient between the right ventricle (RV) and right 
atrium (RA). The estimated right atrial pressure was added to 
this parameter,11,12 given that there was no right ventricular out-
flow tract obstruction.
Right atrial pressure was obtained by assessing the percent-
age collapse and the diameter of the inferior vena cava during 
spontaneous breathing. If the inspiratory collapse was greater 
than 50% and the diameter was less than 2.1 cm, the pressure 
added was 5 mmHg; if the inspiratory collapse was less than 50% 
and the diameter was greater than 2.1 cm, the pressure added was 
10 mmHg; in patients where the inferior vena cava plethora was 
markedly greater than 2.1 cm and collapse was less than 50%, the 
pressure added was 20 mmHg.13-15
Pulmonary hypertension criteria
Pulmonary hypertension was considered “probable” when PASP 
was greater than 50 mmHg.15,16 It was considered “possible” when 
PASP fluctuated between 37 and 50 mmHg, or when it was below 
37 mmHg and accompanied by additional echocardiographic 
variables of PH, including the existence of dilation and/or hyper-
trophy of the right chambers, paradoxical movement of the 
interventricular septum or right  ventricular dysfunction (ana-
lyzed in accordance with the recommendations of the American 
Society of Echocardiography for evaluating the right chambers).15
Data analysis
Continuous variables were described as the mean plus or minus 
standard deviation, along with the amplitude. Categorical vari-
ables were expressed as percentages. We conducted analyses 
on the correlations of the amplitudes of S2 and P2 in relation 
to PASP with the aim of assessing the influence of one vari-
able on  another. Since these variables did not show normal 
distribution according to the Shapiro-Wilk test, the Spearman 
correlation coefficient was used.
A receiver operating characteristic (ROC) curve with its 
components of sensitivity (S), specificity (Sp) and positive (LR+) 
and negative (LR-) likelihood ratios was constructed in order to 
determine the discriminatory power of each parameter studied. 
The area under the curve was expressed in terms of the 95% con-
fidence interval (95% CI).
The findings were considered statistically significant when 
the probability P for two-tailed tests was P < 0.05. The data were 
analyzed using the Statistical Package for the Social Sciences 
(SPSS) software version 20 and Excel, both for the Mac OS X 
operating system.
RESULTS
The prevalence of PH in the sample, when all the echocardio-
graphic criteria were taken into consideration, was 73% in 
patients with idiopathic pulmonary fibrosis, 41% in those with 
idiopathic diseases, 27% in those with collagen-vascular dis-
ease, 22% in those with sarcoidosis, 25% in those with chronic 
hypersensitivity pneumonia and 25% in those with other diffuse 
lung diseases. In these patients, the forced vital capacity (FVC) 
showed a mean of 67 ± 22.7%, with a minimum value of 18% 
and maximum of 110%. Hemoglobin oxygen saturation (SpO2) 
in ambient air showed a mean of 93.4 ± 4.8% and a minimum 
value of 70% and maximum of 99%.
PASP estimated by means of Doppler echocardiogra-
phy (which was feasible in all tests) was normal in 41 patients 
(59.4%), while 17 (24.7%) had additional echocardiographic cri-
teria that, together with PASP, were suggestive of PH (possible 
PH). In 11 patients (15.9%), the PASP values measured by means 
of Doppler indicated PH (probable PH). Therefore, the combina-
tion of all the criteria measured through the examination led us 
to observe PH in 28 patients (40.6%).
Table 1 shows the frequencies of the clinical findings stud-
ied. For each analysis of S and Sp, we observed low values for 
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all phonocardiographic parameters, in comparison with Doppler 
echocardiographic criteria, as shown in Tables 2 and 3.
From observing the behavior of the maximum amplitude 
of S2 on phonocardiography (with or without splitting) and 
the amplitude of P2, in relation to the variation of PASP, we 
obtained a weak and not statistically significant correlation. The 
correlation index ρ was 0.185 for S2 (P = 0.13) and 0.115 for P2 
(P = 0.34).
In assessing the ROC curve, the best cutoff point for PASP 
was defined as 53 mmHg. At this pressure, simultaneous pres-
ence of the three clinical signs studied showed LR+ = 2.32 and 
LR- = 0.88. The area under the curve was 0.518 (95% CI: 0.376 
to 0.659; P = 0.80). This value was very close to the limit set for 
probable PH. Considering the pretest probability to be the preva-
lence of PH above 53 mmHg within the sample studied (which 
was 13%), the post-test probability would increase to 26%. For 
each clinical sign isolated, there were no points on the curve that 
yielded LR+ greater than 2 or LR- less than 0.5.
DISCUSSION
This study included patients with several types of interstitial lung 
diseases, with different FVC values and degrees of hypoxemia at 
the time of evaluation. We observed a range of situations: normal 
PASP values, mild degrees of PH and also markedly elevated levels 
of the disease, which constituted the later stages of this comorbidity.  
The prevalence of PH in these diseases varies widely accord-
ing to the diagnosis and pulmonary involvement. It is also a pre-
dictor of morbidity and mortality.17-19
Doppler echocardiography has been used in other clini-
cal studies to trace PH, in which the prevalence of this disorder 
was between 5.7% and 73.8% when pulmonary involvement was 
due to sarcoidosis.20 In interstitial diseases relating to collage-
nosis, especially scleroderma, the prevalence of PH was around 
18.1%.21 In idiopathic pulmonary fibrosis, these data are not yet 
well defined, with the possibility of reaching 84% in patients with 
advanced degrees of pulmonary involvement.22 Other authors 
have also demonstrated its occurrence in one third of patients 
with IPF (interstitial pulmonary fibrosis).23 In the present study, 
the prevalence rates of PH were in agreement with the range of 
values previously reported.
Since the recognition of inspiratory splitting of the second 
heart sound by Potain24 100 years ago, numerous studies have 
tried to explain how these heart sound variations occur and 
whether these changes can be attributed to various disorders. 
Analyses have been conducted with the aim of comparing tra-
ditional phonocardiograms with intracardiac pressure measure-
ments made through cardiac catheterization, in order to relate 
pressure values to semiological findings. 
There are no studies comparing intracardiac pressure mea-
surements obtained using Doppler echocardiography with digi-
tal phonocardiogram pulse tracings obtained using an electronic 
stethoscope, in which patients with interstitial lung disease were 
specifically targeted. However, the reasons that would lead to 
increased PASP and possible semiological changes would be sim-
ilar to those found in other diseases.
The relative intensities of heart sounds are still an integral part 
of auscultation. In cases of PH, the explanation for findings that 
the pulmonary component of the second heart sound presents 
greater intensity than that of the aortic component is believed 
to be associated with hemodynamic concepts and factors relat-
ing to the anatomy of the pulmonary artery.25 However, there is 
still controversy about the exact mechanism of this phenomenon. 
Earlier studies25-27 indicated that the amplitude of the P2 
component in PH may not differ significantly from that of A2. 
This would be explained by the fact that although the diastolic 
pressure gradient in the right ventricle is elevated in this condi-
tion, it would not exceed the gradient of the left chamber. In this 
regard, increased amplitude of the P2 component could only be 
Table 1. Frequencies of clinical findings surveyed






S2 more intense in the pulmonic  
area than in the aortic area
49 (71.0%) 20 (29.0%)
P2 > A2 41 (59.4%) 28 (40.6%)*
P2 in the mitral area 43 (62.3%) 26 (37.7%)
All signs present simultaneously 32 (46.4%) 37 (53.6%)
Table 2. Comparison between clinical findings predictive of 
pulmonary hypertension (probable) 
S Sp LR+ LR- P
S2 more intense in the pulmonic  
area than in the aortic area
63% 27% 0.9 1.3 0.50
P2 > A2 63% 41% 1.0 0.9 0.90
P2 in the mitral area 63% 37% 1.0 0.9 0.90
All signs present simultaneously 63% 57% 1.4 0.6 0.20
S = sensitivity; Sp = specificity; LR+ = positive likelihood ratio; and 
LV- = negative likelihood ratio.
Table 3. Comparison between clinical findings predictive of 
pulmonary hypertension (possible and probable)
S = sensitivity; Sp = specificity; LR+ = positive likelihood ratio; and 
LV- = negative likelihood ratio.
S Sp LR+ LR- P
S2 more intense in the pulmonic  
area than in the aortic area
60% 22% 0.7 1.7 0.12
P2 > A2 57% 39% 0.9 1.1 0.70
P2 in the mitral area 68% 41% 1.1 0.7 0.40
All signs present simultaneously 50% 56% 1.1 0.9 0.60
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expected in those few patients with PH in the later stages of the 
disease, in which the rate of increase of this gradient would be 
extremely high. Nevertheless, the analysis on this component did 
not show statistical significance.25
One anatomical factor that could also contribute towards 
greater amplitude of P2 in cases of PH would be greater surface 
area of the pulmonary valve and higher pulmonary artery disten-
sibility, which would produce intense vibration of the semilunar 
valves, in comparison with the aortic valve. The combination of 
these factors was significant.26,27 The data from our study were 
consistent with the facts previously described and also showed no 
relationship between higher amplitude of the P2 component mea-
sured by means of phonocardiography and elevated PASP levels 
measured by Doppler echocardiography.
The PASP values estimated by means of color Doppler echo-
cardiography showed a good correlation with invasive measure-
ments (r = 0.92). The S and Sp values for predicting PH ranged 
from 79 to 100% for S and from 60 to 98% for Sp, in a study show-
ing high prevalence of PH.28
Through evaluating the presence of clinical findings sugges-
tive of PH and comparing the data with measurements of PASP by 
means of Doppler echocardiography, we noted that our values for S 
and Sp and the ratios for LR+ and LR- were of low clinical relevance, 
even when the pulmonary pressure levels were high. The findings 
from clinical studies that did not report any relationship between the 
relative intensities of the components of S2 found through phonocar-
diography and measurements of pulmonary pressure through cath-
eterization29 are in agreement with these data. Other clinical findings 
such as P2 with higher amplitude than A2 and the presence of P2 in 
the mitral area were also compared in other studies in which pres-
sure measurements were made by means of catheterization. There 
was no relationship between elevated measurements and the exis-
tence of these signs. In this context, the S and Sp values for high-
amplitude P2 components were respectively 58-96% and 19-46%, 
thus demonstrating a wide variation.5,7
So far, the results from rigorous analysis on the S and Sp of 
semiological findings predictive of PH that were associated with 
the second heart sound have not been conclusive. However, our 
results showed that the discriminatory power of each of the clini-
cal parameters evaluated was not very important for the diagnos-
tic suspicion of PH “at the bedside”. 
It should be noted that even the data from the NIH registry, 
which was a relevant prospective study, refer to the existence of 
an accentuated pulmonary component of the second heart sound, 
seen on clinical examination in more than 90% of the patients 
with PH, irrespective of its cause.30 However, the NIH study aimed 
to investigate factors associated with survival in this population. 
The only concern was to report the clinical findings, without deter-
mining the S and Sp of these semiological findings.
Thus, considering a context in which the prevalence of PH 
is high, findings of physical signs with high Sp would increase 
the likelihood of the disease post-test. Absence of signs showing 
high S would practically dismiss this possibility, and this would 
be useful for tracing. Our data demonstrated that these signs do 
not have the capacity to confirm the presence or absence of the 
disease. Other methods such as Doppler echocardiography are 
required in order to diagnose this complication.
CONCLUSIONS
Therefore, we can conclude that, in the context of symptomatic 
evaluation for predicting PH in patients with interstitial diseases, 
clinical signs are not useful. Their pathophysiological concepts 
would only be useful for academic thinking. These signs cannot 
take on the function of reaching a diagnosis. 
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